Publisher
Springer Berlin Heidelberg
Reference181 articles.
1. Abrams JA, Rayner A, Wiernik D, Parkinson D (1989) High dose interleukin-2 without lymphokine activated killer cells. Inactive in advanced renal cell cancer. Proc AACR 30 A:1507
2. Alexander RB, Walther MC, Linehan WM (1993) Immunotherapy of renal cell carcinoma: Experience of the Surgery Branch. National Cancer Institute. Adv Urol 6:101–125
3. Anderson MW, Reynolds SH, You M, Maronpot RM (1992) Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect 98:13–24
4. Atzpodien J, Körfer A, Franks C et al. (1990) Home therapy with recombinant interleukin-2 and interferon alpha-2 in advanced human malignancies. Lancet 335:1509–1512
5. Atzpodien J, Kirchner H, Hanninen EL et al. (1993) Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer. Eur J Cancer 29A [Suppl 6]:S6–S8